Alpha Teknova, Inc.

Alpha Teknova, Inc. (TKNO) priced its initial public offering on Jun 25, 2021 at $16.00 per share, raising $96M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $433.8M. TD Cowen was lead-left underwriter, joined by William Blair, BTIG and Stephens. Paul Hastings advised the company and DLA Piper advised the underwriters.

Alpha Teknova, Inc. supplies reagents used in discovering, researching, developing and producing biopharmaceuticals such as drug therapies, vaccines and molecular diagnostics. Its custom, made-to-order products serve pharmaceutical and biotech companies, contract manufacturers, diagnostics firms and academic and government researchers.

Status

IPO

Ticker

TKNO

Exchange

Nasdaq Global Market

Priced

Jun 25, 2021

IPO price

$16.00

Raised

$96M

Market cap at IPO price

$433.8M

First filed

Jun 4, 2021

Underwriters

TD Cowen, William Blair, BTIG and Stephens

Company counsel

Paul Hastings

Underwriters' counsel

DLA Piper

Sector

Biotech & pharma

Country / state

CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.